BR112021020144A2 - Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois - Google Patents

Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois

Info

Publication number
BR112021020144A2
BR112021020144A2 BR112021020144A BR112021020144A BR112021020144A2 BR 112021020144 A2 BR112021020144 A2 BR 112021020144A2 BR 112021020144 A BR112021020144 A BR 112021020144A BR 112021020144 A BR112021020144 A BR 112021020144A BR 112021020144 A2 BR112021020144 A2 BR 112021020144A2
Authority
BR
Brazil
Prior art keywords
amyelois
transposase
transposition
nucleic acid
gene
Prior art date
Application number
BR112021020144A
Other languages
English (en)
Inventor
Jeremy Minshull
Maggie Lee
Sridhar Govindarajan
Original Assignee
Dna Twopointo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dna Twopointo Inc filed Critical Dna Twopointo Inc
Publication of BR112021020144A2 publication Critical patent/BR112021020144A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/90Vectors containing a transposable element
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/007Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Ticket-Dispensing Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois. a presente invenção fornece vetores polinucleotídicos para alta expressão de genes heterólogos. alguns vetores compreendem adicionalmente novos transposons e transposases que melhoram ainda mais a expressão. além disso, são divulgados vetores que podem ser usados em um sistema de transferência de genes para a introdução estável de ácidos nucleicos no dna de uma célula. os sistemas de transferência de genes podem ser usados em métodos, por exemplo, expressão gênica, bioprocessamento, terapia gênica, mutagênese por inserção ou descoberta de genes.
BR112021020144A 2019-04-08 2020-04-07 Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois BR112021020144A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962831097P 2019-04-08 2019-04-08
US201962873342P 2019-07-12 2019-07-12
US202062990568P 2020-03-17 2020-03-17
PCT/US2020/027078 WO2020210237A1 (en) 2019-04-08 2020-04-07 Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois

Publications (1)

Publication Number Publication Date
BR112021020144A2 true BR112021020144A2 (pt) 2021-12-14

Family

ID=72663758

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021020144A BR112021020144A2 (pt) 2019-04-08 2020-04-07 Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois

Country Status (11)

Country Link
US (3) US11060109B2 (pt)
EP (1) EP3953479A4 (pt)
JP (1) JP7418469B2 (pt)
KR (1) KR20210144861A (pt)
CN (1) CN112513277B (pt)
AU (1) AU2020272667B2 (pt)
BR (1) BR112021020144A2 (pt)
CA (1) CA3125043A1 (pt)
IL (2) IL287088B2 (pt)
SG (1) SG11202107383RA (pt)
WO (1) WO2020210237A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11060086B2 (en) 2019-04-08 2021-07-13 Dna Twopointo Inc. Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis
CA3125047A1 (en) * 2019-04-08 2020-10-15 Dna Twopointo Inc. Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
CN112513277B (zh) 2019-04-08 2024-07-23 Dna2.0股份有限公司 使用来自螟蛾属的转座酶将核酸构建体转座入真核基因组
WO2021226141A1 (en) 2020-05-04 2021-11-11 Saliogen Therapeutics, Inc. Transposition-based therapies
WO2022204067A1 (en) * 2021-03-24 2022-09-29 Dna Twopointo Inc. Tetracycline-inducible expression systems
CN116445542A (zh) * 2022-01-10 2023-07-18 佛山汉腾生物科技有限公司 表达载体及其应用
WO2024068995A1 (en) 2022-09-30 2024-04-04 Boehringer Ingelheim International Gmbh Novel transposase system
CN116590341A (zh) * 2023-07-13 2023-08-15 山东维真生物科技有限公司 一种腺病毒-PiggyBac***及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560542B2 (en) 1999-05-07 2009-07-14 Monsanto Technology Llc Nucleic acid molecule SEQ ID NO. 68811 and other molecules associated with plants
US6518064B1 (en) * 2000-03-29 2003-02-11 The Regents Of The University Of California Pink bollworm expression system for commercially valuable protein production
US7932088B1 (en) 2005-04-25 2011-04-26 University Of Notre Dame Du Lac High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac
CN101297031B (zh) * 2005-05-14 2013-06-05 复旦大学 在脊椎动物中作为遗传操作和分析工具的piggyBac
US8741340B2 (en) 2009-01-23 2014-06-03 Nsgene A/S Cell lines and their use in encapsulated cell biodelivery
US20110311506A1 (en) 2009-02-25 2011-12-22 The Johns Hopkins University Piggybac transposon variants and methods of use
CN102803484A (zh) * 2009-06-11 2012-11-28 大学共同利用机关法人情报·***研究机构 生产蛋白质的方法
EP2678434B1 (en) * 2011-02-25 2018-11-07 Recombinetics, Inc. Genetically modified animals and methods for making the same
ES2679995T3 (es) * 2011-03-11 2018-09-03 Vib Vzw Moléculas y métodos para la inhibición y detección de proteínas
WO2014191146A1 (en) * 2013-04-29 2014-12-04 Agrosavfe N.V. Agrochemical compositions comprising antibodies binding to sphingolipids
US10233454B2 (en) * 2014-04-09 2019-03-19 Dna2.0, Inc. DNA vectors, transposons and transposases for eukaryotic genome modification
US20150291975A1 (en) * 2014-04-09 2015-10-15 Dna2.0, Inc. Enhanced nucleic acid constructs for eukaryotic gene expression
ES2891087T3 (es) * 2015-10-08 2022-01-26 Dna Twopointo Inc Vectores de ADN, trasposones y transposasas para la modificación del genoma eucariota
CA3125047A1 (en) * 2019-04-08 2020-10-15 Dna Twopointo Inc. Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
CN112513277B (zh) * 2019-04-08 2024-07-23 Dna2.0股份有限公司 使用来自螟蛾属的转座酶将核酸构建体转座入真核基因组
US11060086B2 (en) 2019-04-08 2021-07-13 Dna Twopointo Inc. Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis
US20230313187A1 (en) * 2020-09-04 2023-10-05 Dna Twopointo Inc. Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their products

Also Published As

Publication number Publication date
AU2020272667A1 (en) 2021-07-15
CN112513277A (zh) 2021-03-16
JP2022527016A (ja) 2022-05-27
US20210324408A1 (en) 2021-10-21
US11396662B2 (en) 2022-07-26
IL287088B2 (en) 2023-09-01
IL287088B1 (en) 2023-05-01
US11060109B2 (en) 2021-07-13
IL301621A (en) 2023-05-01
JP7418469B2 (ja) 2024-01-19
US20200318135A1 (en) 2020-10-08
AU2020272667B2 (en) 2023-07-06
EP3953479A4 (en) 2023-01-11
KR20210144861A (ko) 2021-11-30
EP3953479A1 (en) 2022-02-16
SG11202107383RA (en) 2021-08-30
WO2020210237A1 (en) 2020-10-15
CA3125043A1 (en) 2020-10-15
CN112513277B (zh) 2024-07-23
IL287088A (en) 2021-12-01
US20220411816A1 (en) 2022-12-29

Similar Documents

Publication Publication Date Title
BR112021020144A2 (pt) Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois
BR112021020143A2 (pt) Integração de construções de ácidos nucleicos com células eucarióticas com uma transposase de oryzias
US20230279443A1 (en) Cas9 proteins including ligand-dependent inteins
US20200277587A1 (en) Evolution of talens
US10301613B2 (en) Targeted remodeling of prokaryotic genomes using CRISPR-nickases
BR112021012665A2 (pt) Polipeptídeos úteis para edição de genes e métodos de uso
WO2017062668A3 (en) Dna vectors, transposons and transposases for eukaryotic genome modification
Li et al. A versatile reporter system for CRISPR-mediated chromosomal rearrangements
US20180044659A1 (en) Methods and kits for fragmenting dna
WO2017024602A1 (zh) 一种测定非同源末端连接修复活性的方法
JP2018522544A (ja) 熱安定性cas9ヌクレアーゼ
ES2690386T3 (es) Composición para escindir un ADN diana que comprende un ARN guía específico para el ADN diana y el ácido nucleico que codifica la proteína Cas o la propia proteína Cas, y sus usos
Zhang et al. Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter
US20220243184A1 (en) ENGINEERED Cas-Transposon SYSTEM FOR PROGRAMMABLE AND SITE-DIRECTED DNA TRANSPOSITIONS
Javidi-Parsijani et al. No evidence of genome editing activity from Natronobacterium gregoryi Argonaute (NgAgo) in human cells
Vriend et al. Assaying break and nick-induced homologous recombination in mammalian cells using the DR-GFP reporter and Cas9 nucleases
BR112022002695A2 (pt) Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso
Kalliomaa-Sanford et al. Chromosome segregation in Archaea mediated by a hybrid DNA partition machine
Sun et al. SunnyTALEN: A second‐generation TALEN system for human genome editing
BR112020025319A2 (pt) Composições, sistemas e métodos de amplificação baseada em crispr/cas e transposase
Zhang et al. A simple TALEN-based protocol for efficient genome-editing in Drosophila
Nievergelt et al. Efficient precision editing of endogenous Chlamydomonas reinhardtii genes with CRISPR-Cas
US20230032136A1 (en) Method for determination of 3d genome architecture with base pair resolution and further uses thereof
Wang et al. Research of methods to detect genomic mutations induced by CRISPR/Cas systems
Vinayak et al. Genetic manipulation of the Toxoplasma gondii genome by fosmid recombineering